U.S., Dec. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07282886) titled 'VENTURI (VENTilation Using Respiratory Imaging)' on Nov. 21.
Brief Summary: The purpose of the study is to enroll participants with uncontrolled asthma to evaluate the large and small airways and drug delivery utilizing two study drugs:
* Beclometasone dipropionate/Formoterol fumarate dihydrate/Glycopyrronium bromide (BDP/FF/G) or Trimbow
* Fluticasone furoate/Umeclidinium/Vilanterol (FluF/UMEC/VI ) or Trelegy Ellipta
Study Start Date: Dec. 15
Study Type: INTERVENTIONAL
Condition:
Asthma
Intervention:
DRUG: Beclomethasone Dipropionate/Formoterol Fumarate/Glycopyrrolate pMDI
pMDI,100/6/12.5 mcg per inhalation
DRUG: Fluticas...